Meeting
2020 ASCO Virtual Scientific Program
Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (NSCLC) patients on immunotherapy.
Authors
Francesco Vallania
Freenome, South San Francisco, CA
Francesco Vallania , Karen Assayag , Peter Ulz , Adam Drake , Hayley Warsinske , John St John , Girish Putcha , Luc Cabel , Sophie Beaucaire-Danel , Nicolas Girard , Francois-Clement Bidard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9588)
DOI
10.1200/JCO.2020.38.15_suppl.9588
Abstract #
9588
Poster Bd #
354
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma.
First Author: Yuval Shaked
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Tumor mutational burden as a potential predictive marker for the efficacy of immunotherapy in advanced gastric cancer.
First Author: Jae Yeon Jang
Poster
2021 ASCO Annual Meeting
Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.
First Author: Carlo Guerrero
Poster
2019 ASCO Annual Meeting
Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response.
First Author: Joshua E. Reuss